Saltar al contenido
Merck

A New Opportunity for "Old" Molecules: Targeting PARP1 Activity through a Non-Enzymatic Mechanism.

International journal of molecular sciences (2023-05-27)
Pablo Iglesias, Marcos Seoane, Irene Golán-Cancela, Máximo Fraga, Victor M Arce, Jose A Costoya
RESUMEN

In recent years, new therapies have been developed based on molecules that target molecular mechanisms involved in both the initiation and maintenance of the oncogenic process. Among these molecules are the poly(ADP-ribose) polymerase 1 (PARP1) inhibitors. PARP1 has emerged as a target with great therapeutic potential for some tumor types, drawing attention to this enzyme and resulting in many small molecule inhibitors of its enzymatic activity. Therefore, many PARP inhibitors are currently in clinical trials for the treatment of homologous recombination (HR)-deficient tumors, BRCA-related cancers, taking advantage of synthetic lethality. In addition, several novel cellular functions unrelated to its role in DNA repair have been described, including post-translational modification of transcription factors, or acting through protein-protein interactions as a co-activator or co-repressor of transcription. Previously, we reported that this enzyme may play a key role as a transcriptional co-activator of an important component of cell cycle regulation, the transcription factor E2F1. Here, we show that PARP inhibitors, which interfere with its activity in cell cycle regulation, perform this without affecting its enzymatic function.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cicloheximida, from microbial, ≥94% (TLC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Anti-α-tubulina monoclonal antibody produced in mouse, ascites fluid, clone B-5-1-2
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Anticuerpo anti-actina, clon C4, ascites fluid, clone C4, Chemicon®
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
(±)-Gossypol from cotton seeds, ≥95% (HPLC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Anti-phospho-H2A.X (Ser139) Antibody, Upstate®, from rabbit
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
PARP Inhibitor VIII, PJ34, The PARP Inhibitor VIII, PJ34, also referenced under CAS 344458-15-7, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications.
En este momento no podemos mostrarle ni los precios ni la disponibilidad